Covered recipient · General Payments record
JODIE D HARRISON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Gerontology
General Payments · PY2021–2024
$9,452.53
- Reported across 300 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,910.88 | 60 |
| Education | $198.99 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $353.24 | 11 |
| Adaptive Biotechnologies Corporation | $313.71 | 3 |
| Astellas Pharma US Inc | $171.22 | 4 |
| Astellas Pharma Global Development | $159.00 | 1 |
| BeiGene USA, Inc. | $147.80 | 2 |
| Pharmacosmos Therapeutics Inc. | $125.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $98.54 | 6 |
| Daiichi Sankyo Inc. | $69.49 | 3 |
| Gilead Sciences, Inc. | $69.40 | 2 |
| SpringWorks Therapeutics, Inc. | $67.41 | 1 |
| Merck Sharp & Dohme Corporation | $50.13 | 2 |
| Celgene Corporation | $48.04 | 3 |
| PROGENICS PHARMACEUTICALS, INC. | $41.56 | 2 |
| Genentech USA, Inc. | $39.45 | 2 |
| PFIZER INC. | $39.30 | 2 |
| Lilly USA, LLC | $37.79 | 2 |
| GENZYME CORPORATION | $36.70 | 1 |
| Acerta Pharma LLC | $33.32 | 2 |
| ABBVIE INC. | $33.29 | 2 |
| EISAI INC. | $23.38 | 1 |
| Stemline Therapeutics Inc. | $21.92 | 1 |
| Ipsen Biopharmaceuticals, Inc | $19.05 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.22 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.71 | 1 |
| Incyte Corporation | $15.90 | 1 |
| SHIELD THERAPEUTICS INC | $15.59 | 1 |
| Apellis Pharmaceuticals, Inc. | $15.40 | 1 |
| EMD Serono, Inc. | $14.94 | 1 |
| ARRAY BIOPHARMA INC | $14.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (62)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.